167 related articles for article (PubMed ID: 31334753)
1. S100A8/A9 as a therapeutic target in myocardial infarction: cellular mechanisms, molecular interactions, and translational challenges.
Frangogiannis NG
Eur Heart J; 2019 Aug; 40(32):2724-2726. PubMed ID: 31334753
[No Abstract] [Full Text] [Related]
2. S100A8/A9 in Myocardial Infarction.
Sreejit G; Nooti SK; Athmanathan B; Nagareddy PR
Methods Mol Biol; 2019; 1929():739-754. PubMed ID: 30710308
[TBL] [Abstract][Full Text] [Related]
3. S100A8/A9 as a prognostic biomarker with causal effects for post-acute myocardial infarction heart failure.
Ma J; Li Y; Li P; Yang X; Zhu S; Ma K; Gao F; Gao H; Zhang H; Ma XL; Du J; Li Y
Nat Commun; 2024 Mar; 15(1):2701. PubMed ID: 38538601
[TBL] [Abstract][Full Text] [Related]
4. The Association Between S100A8/A9 and the Development of Very Late Stent Thrombosis in Patients With Acute Myocardial Infarction.
Wang X; Guan M; Zhang X; Ma T; Wu M; Li Y; Chen X; Zheng Y
Clin Appl Thromb Hemost; 2020; 26():1076029620943295. PubMed ID: 32734774
[TBL] [Abstract][Full Text] [Related]
5. S100A8/A9 Enhances Immunomodulatory and Tissue-Repairing Properties of Human Amniotic Mesenchymal Stem Cells in Myocardial Ischemia-Reperfusion Injury.
Chen TJ; Yeh YT; Peng FS; Li AH; Wu SC
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681835
[TBL] [Abstract][Full Text] [Related]
6. S100a8/a9 Signaling Causes Mitochondrial Dysfunction and Cardiomyocyte Death in Response to Ischemic/Reperfusion Injury.
Li Y; Chen B; Yang X; Zhang C; Jiao Y; Li P; Liu Y; Li Z; Qiao B; Bond Lau W; Ma XL; Du J
Circulation; 2019 Aug; 140(9):751-764. PubMed ID: 31220942
[TBL] [Abstract][Full Text] [Related]
7. S100A8/A9 promotes MMP-9 expression in the fibroblasts from cardiac rupture after myocardial infarction by inducing macrophages secreting TNFα.
Shi S; Yi JL
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3925-3935. PubMed ID: 29949169
[TBL] [Abstract][Full Text] [Related]
8. The role of myofibroblasts in upregulation of S100A8 and S100A9 and the differentiation of myeloid cells in the colorectal cancer microenvironment.
Kim JH; Oh SH; Kim EJ; Park SJ; Hong SP; Cheon JH; Kim TI; Kim WH
Biochem Biophys Res Commun; 2012 Jun; 423(1):60-6. PubMed ID: 22634002
[TBL] [Abstract][Full Text] [Related]
9. S100A8 and S100A9: DAMPs at the crossroads between innate immunity, traditional risk factors, and cardiovascular disease.
Schiopu A; Cotoi OS
Mediators Inflamm; 2013; 2013():828354. PubMed ID: 24453429
[TBL] [Abstract][Full Text] [Related]
10. Enhanced expression of the S100A8/A9 complex in acute myocardial infarction patients.
Katashima T; Naruko T; Terasaki F; Fujita M; Otsuka K; Murakami S; Sato A; Hiroe M; Ikura Y; Ueda M; Ikemoto M; Kitaura Y
Circ J; 2010 Apr; 74(4):741-8. PubMed ID: 20190427
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of pro-inflammatory myeloid cell responses by short-term S100A9 blockade improves cardiac function after myocardial infarction.
Marinković G; Grauen Larsen H; Yndigegn T; Szabo IA; Mares RG; de Camp L; Weiland M; Tomas L; Goncalves I; Nilsson J; Jovinge S; Schiopu A
Eur Heart J; 2019 Aug; 40(32):2713-2723. PubMed ID: 31292614
[TBL] [Abstract][Full Text] [Related]
12. Response by Sreejit and Nagareddy to Letter Regarding Article, "Neutrophil-Derived S100A8/A9 Amplify Granulopoiesis After Myocardial Infarction".
Sreejit G; Nagareddy PR
Circulation; 2020 Sep; 142(9):e125-e126. PubMed ID: 32866066
[No Abstract] [Full Text] [Related]
13. Letter by Wang et al Regarding Article, "Neutrophil-Derived S100A8/A9 Amplify Granulopoiesis After Myocardial Infarction".
Wang D; Wang T; Yang X
Circulation; 2020 Sep; 142(9):e123-e124. PubMed ID: 32866064
[No Abstract] [Full Text] [Related]
14. Increased myeloid-derived suppressor cells in gastric cancer correlate with cancer stage and plasma S100A8/A9 proinflammatory proteins.
Wang L; Chang EW; Wong SC; Ong SM; Chong DQ; Ling KL
J Immunol; 2013 Jan; 190(2):794-804. PubMed ID: 23248262
[TBL] [Abstract][Full Text] [Related]
15. NETosis Is Required for S100A8/A9-Induced Granulopoiesis After Myocardial Infarction.
Nagareddy PR; Sreejit G; Abo-Aly M; Jaggers RM; Chelvarajan L; Johnson J; Pernes G; Athmanathan B; Abdel-Latif A; Murphy AJ
Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2805-2807. PubMed ID: 32878477
[TBL] [Abstract][Full Text] [Related]
16. Platelet-Derived S100A8/A9 and Cardiovascular Disease in Systemic Lupus Erythematosus.
Lood C; Tydén H; Gullstrand B; Jönsen A; Källberg E; Mörgelin M; Kahn R; Gunnarsson I; Leanderson T; Ivars F; Svenungsson E; Bengtsson AA
Arthritis Rheumatol; 2016 Aug; 68(8):1970-80. PubMed ID: 26946461
[TBL] [Abstract][Full Text] [Related]
17. [S100A8/A9 and periodontal inflammatory diseases].
Gao HY; Meng HX; Hou JX
Zhonghua Kou Qiang Yi Xue Za Zhi; 2020 Sep; 55(9):679-684. PubMed ID: 32878406
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil-Derived Protein S100A8/A9 Alters the Platelet Proteome in Acute Myocardial Infarction and Is Associated With Changes in Platelet Reactivity.
Joshi A; Schmidt LE; Burnap SA; Lu R; Chan MV; Armstrong PC; Baig F; Gutmann C; Willeit P; Santer P; Barwari T; Theofilatos K; Kiechl S; Willeit J; Warner TD; Mathur A; Mayr M
Arterioscler Thromb Vasc Biol; 2022 Jan; 42(1):49-62. PubMed ID: 34809447
[TBL] [Abstract][Full Text] [Related]
19. Myeloid marker S100A8/A9 and lymphocyte marker, soluble interleukin 2 receptor: biomarkers of hidradenitis suppurativa disease activity?
Wieland CW; Vogl T; Ordelman A; Vloedgraven HG; Verwoolde LH; Rensen JM; Roth J; Boer J; Hessels J
Br J Dermatol; 2013 Jun; 168(6):1252-8. PubMed ID: 23320892
[TBL] [Abstract][Full Text] [Related]
20. S100A8/A9: An emerging player in sepsis and sepsis-induced organ injury.
Wang Q; Long G; Luo H; Zhu X; Han Y; Shang Y; Zhang D; Gong R
Biomed Pharmacother; 2023 Dec; 168():115674. PubMed ID: 37812889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
